Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Management of spasticity

S Hesse1, K H Mauritz

  • 1Berlin Clinic, Department of Neurological Rehabilitation, Free University Berlin, Germany.

Current Opinion in Neurology
|January 13, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Herpes zoster in children during the COVID-19 pandemic in France: A retrospective multicenter observational study.

Annales de dermatologie et de venereologie·2023
Same author

[Nuclear medicine diagnostics in Wilson's disease].

Der Nervenarzt·2022
Same author

Video-oculography in multiple sclerosis: Links between oculomotor disorders and brain magnetic resonance imaging (MRI).

Multiple sclerosis and related disorders·2020
Same author

Corrigendum to "Association of electroencephalogram trajectories during emergence from anaesthesia with delirium in the postanaesthesia care unit: an early sign of postoperative complications" (Br J Anaesth 2019; 122: 622-634).

British journal of anaesthesia·2019
Same author

Association of electroencephalogram trajectories during emergence from anaesthesia with delirium in the postanaesthesia care unit: an early sign of postoperative complications.

British journal of anaesthesia·2019
Same author

[PROtocol-based MObilizaTION on intensive care units : Design of a cluster randomized pilot study].

Medizinische Klinik, Intensivmedizin und Notfallmedizin·2017
Same journal

Movement disorders and Parkinson's disease: collaborative and interdisciplinary research to advance understanding of neural circuit dysfunction, pathophysiology, and care: new horizons in technology, neuroimaging, neurophysiology, and genetics toward personalized medicine.

Current opinion in neurology·2026
Same journal

Editorial introduction.

Current opinion in neurology·2026
Same journal

Multimodal mapping of balance dysfunction in Parkinson's disease: a consensus roadmap for research and intervention.

Current opinion in neurology·2026
Same journal

Tourette syndrome: brain neurophysiology, circuit dysfunction, and neuromodulation across invasive and noninvasive approaches.

Current opinion in neurology·2026
Same journal

Dystonia: from phenotypes to genetics and therapeutic advances.

Current opinion in neurology·2026
Same journal

What can we learn from eye movements in movement disorders and Parkinson's disease?

Current opinion in neurology·2026
See all related articles

Botulinum toxin A shows promise for treating focal spasticity in adults and children. Enhancing its effects with electrical stimulation and exploring new options like magnetic stimulation are key areas of research.

Area of Science:

  • Neurology
  • Rehabilitation Medicine

Background:

  • Focal spasticity presents a significant challenge in neurological rehabilitation.
  • Botulinum toxin A is increasingly recognized for its therapeutic potential in managing spasticity.

Purpose of the Study:

  • To review the efficacy and safety of Botulinum toxin A in treating focal spasticity.
  • To explore potential mechanisms of action and adjunctive therapies.

Main Methods:

  • Analysis of recent open-label and placebo-controlled studies on Botulinum toxin A.
  • Review of emerging therapeutic strategies for spasticity management.

Main Results:

  • Botulinum toxin A demonstrates effectiveness in reducing focal spasticity in both adult and pediatric populations.

Related Experiment Videos

  • Potential mechanisms involve extrafusal and intrafusal muscle fiber effects, altering afferent discharge.
  • Electrical stimulation appears to enhance Botulinum toxin A efficacy.
  • Most patients tolerate the treatment well, though rare adverse events like tetraparesis were noted.

    • Conclusions:

    • Botulinum toxin A is a viable treatment for focal spasticity.
    • Adjunctive therapies like electrical stimulation, repetitive magnetic stimulation, and gabapentin warrant further investigation for improved outcomes.